EGFR and triple-negative breast carcinoma: To understand the molecular mechanism of action by which NP-G2-044 decreases the growth of EGFR-high triple-negative breast cancer cells, we investigated the effect of NP-G2-044 on the signaling steps downstream of EGFR (Figure 6E and Figure S3).